Introduction Alcohol dehydrogenases (ADHs) participate in fungal carbon metabolism and redox homeostasis, but the contribution of ADH2 to virulence-associated phenotypes and fluconazole response in Candida albicans ( C. albicans ) remains incompletely defined. Methods An ADH2 deletion mutant, adh2Δ/Δ , was generated in a SC5314 genetic background. Growth kinetics, adhesion, filamentous development, biofilm metabolic activity, cell surface hydrophobicity, intracellular ATP, reactive oxygen species, mitochondrial membrane potential, NAD + /NADH ratio, selected glucose-metabolism-related transcript levels, fluconazole response, and in vivo infection burden were evaluated. Results The adh2Δ/Δ mutant displayed modestly altered growth kinetics and showed a shorter doubling time than SC5314. However, qualitative assays showed reduced adhesion and filamentous development, accompanied by decreased expression of ALS1 , ALS3 , and HWP1 . The mutant displayed increased biofilm metabolic activity but decreased cell surface hydrophobicity, together with increased CSH1 expression. Metabolic analyses showed reduced ATP levels and basal intracellular ROS-sensitive fluorescence, together with an increased NAD + /NADH ratio and elevated mitochondrial membrane potential. Among selected glucose-metabolism-related genes, HXK1 was significantly upregulated after correction for multiple testing, whereas CDC19 , PGI1 , and PGK1 were not significantly altered. The adh2Δ/Δ mutant showed a two-fold increase in fluconazole MIC and stronger growth under FLCZ stress, accompanied by increased ERG11 transcript levels, whereas MDR1 , CDR1 , and CDR2 were not significantly altered after correction for multiple testing; ADH1 was also unchanged. In mice, adh2Δ/Δ infection resulted in higher renal fungal burden and higher residual renal fungal burden after fluconazole treatment. Discussion These findings define an ADH2 deletion-associated phenotypic and metabolic/redox state and provide a hypothesis-generating framework for exploring its association with reduced fluconazole susceptibility in C. albicans .
No takes yet. Share an insight, caveat, or question.
Zheng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: